| HOME >> MEDICINE >> TECHNOLOGY |
Investor Relations Contact:Richard Zaremba
Joe Diaz, Lytham Partners631 694 9555
602 889 9700invest@misonix.com
MISONIX, INC. And Subsidiaries Consolidated Balance SheetsDecember 31, 2012June 30, 2012(Unaudited)(derived from auditedfinancial statements)AssetsCurrent Assets: Cash and cash equivalents$6,855,047$6,273,015 Accounts receivable, less allowancefor doubtful accounts of $184,641 and$155,739, respectively2,328,5333,158,084 Inventories, net4,372,5824,380,841 Prepaid expenses and other current assets195,533306,691 Note receivable-198,117Total current assets13,751,69514,316,748Property, plant and equipment, net778,572891,822Goodwill1,701,0941,701,094Intangible and other assets1,276,8661,403,173Total assets$17,508,227$18,312,837Liabilities and stockholders' equityCurrent liabilities: Accounts payable$1,270,734$1,507,695 Accrued expenses and other current liabilities873,0821,074,932Total current liabilities2,143,8162,582,627Deferred income95,041117,147Deferred lease liability23,40322,996Total liabilities2,262,2602,722,770Commitments and contingenciesStockholders' equity: Capital stock, $0.01 par value - shares authorized 20,000,000, 7,108,845 and 7,082,920 shares issued and 7,031,285 and 7,005,360 shares outstanding, respectively71,08870,829 Additional paid-in capital26,397,52726,132,951 Accumulated deficit(10,811,655)(10,202,720) Treasury stock, at cost, 77,560 shares(410,993)(410,993)Total stockholders' equity15,245,96715,590,067Total liabilities and stockholders' equity$17,508,227$18,312,837
MISONIX, INC. And SubsidiariesConsolidated Statements of OperationsUnauditedThree Mont
'/>"/>
| SOURCE Misonix, Inc. Copyright©2012 PR Newswire. All rights reserved |